PEPFAR has steered U.S. HIV/AIDS relief funding for two decades, now navigating funding shifts as aid cuts reshape programs and data rules in partner countries.
At AIDS 2026 in Rio de Janeiro, a State Department slide displayed a geostrational map with several errors and an AI watermark. The incident has prompted scrutiny of internal processes, with the agency accepting responsibility and vowing review. Coverage notes the broader context of donor funding and program continuity for PEPFAR amid spending shifts.
Uganda reports HIV prevalence stable at 5.9% with 1.496 million adults living with HIV; 85.3% know their status, 99.1% on treatment, 96.5% virally suppressed. In MENA, lenacapavir's global rollout shows affordability gaps and uneven access; six generic manufacturers will produce cheaper versions, but many countries remain excluded, raising concerns over reach of the prevention option.
The United States and Zambia have reached a five-year health package totaling about $3.6 billion, with the U.S. providing roughly $1.5 billion and Zambia contributing around $2.1 billion. Data-sharing terms have been narrowed to information necessary to monitor and evaluate programs, and clauses on sharing patient specimens have been removed. Zimbabwe and Ghana have rejected similar terms.